Jane Weaver
Jane Weaver is managing editor of the health and medical unit at NBC News.
Jane Weaver is managing editor of the health and medical unit at NBC News.
Latest from Jane Weaver
The new CDC director has a plan to fix the agency’s trust problem
The new CDC director Dr. Mandy Cohen is focusing on rebuilding trust in America's top public health agency, including fighting vaccine misinformation.
New immune therapy for advanced melanoma offers hope for hard-to-treat disease
An experimental treatment for advanced melanoma is poised to be the next major advance in cancer treatment, top experts say.
China’s volleyball team wears Covid masks in a game, sparking outrage and a quick reversal
Their comeback was impressive, but the victory for China’s national women’s volleyball team drew more attention than normal because its members were wearing
FDA authorizes Covid vaccine boosters for children 12-15
The Food and Drug Administration on Monday cleared the Pfizer-BioNTech Covid-19 booster dose for children ages 12 to 15.
FDA authorizes COVID-19 vaccine boosters for children 12-15
The Food and Drug Administration cleared the Pfizer-BioNTech COVID-19 booster dose for children ages 12-15 on Monday.
Aaron Rodgers says he's unvaccinated, takes ivermectin and bashes 'woke mob'
"I believe strongly in bodily autonomy and ability to make choices for your body," the embattled Green Bay Packers quarterback said.
If you got the Johnson & Johnson vaccine, do you need another dose?
There's growing anxiety over the highly contagious delta variant in the U.S.
Johnson & Johnson one-dose vaccine works well against delta variant
The immune response lasts at least eight months, according to lab data released by the vaccine maker.
Johnson & Johnson one-dose vaccine works well against delta variant
The immune response lasts at least eight months, according to lab data released by the vaccine maker.
Moderna files for FDA authorization for Covid vaccine in younger teens, adolescents
If cleared by the FDA, Moderna will become the second Covid-19 vaccine available in the U.S. for teens under 18 along with Pfizer-BioNTech's vaccine.
U.K. probing if allergic reactions linked to Pfizer vaccine
British regulators warned that people who with severe allergic reactions shouldn’t get the Pfizer vaccine until their investigation is complete.
